ClinicalTrials.Veeva

Menu

Value of Chest Ultrasonography in ILD Screening

A

Aswan University

Status

Completed

Conditions

Interstitial Lung Disease

Study type

Observational

Funder types

Other

Identifiers

NCT06260930
Value of chest ultrasonography

Details and patient eligibility

About

The main aim of this study is to detect the value of transthoracic ultrasonography in the diagnosis and assessment of ILDs in correlation to chest X- ray, blood gases, pulmonary function test and echocardiography and to compare it with high resolution CT (HRCT) as a golden diagnostic investigation.

Full description

Interstitial lung disease (ILD) refers to a group of disorders that are characterized by varying combinations of inflammation and fibrosis involving the space between the epithelial and endothelial basement membranes.

Enrollment

80 patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Adults (≥18 years) diagnosed with ILD
  • All patients must fulfil the 2018 criteria for HRCT chest finding for the diagnosis of Usual interstitial pneumonia (UIP) form

Exclusion criteria

  • Patients with cardiac diseases (Left-sided Heart failure, pulmonary edema) [they may have findings of multiple B lines on transthoracic ultrasound examination which mimic ILD findings].
  • Patients with chronic kidney diseases (as patients presented with nephrogenic pulmonary edema may have findings of multiple B lines on transthoracic ultrasound examination which mimic ILD findings).

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems